Company

OTR Therapeutics

OTR Therapeutics develops therapies for metabolic diseases.

About

OTR Therapeutics develops biologics and small molecule therapies for metabolic diseases. Founded in 2025, the company is based in Shanghai, China. In June 2025, it raised USD 100 million in Series A funding from True Light Capital, Pfizer Venture Investments, Lilly Asia Ventures, and Sirona Capital. The funding will support development of its pipeline.

1Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in